Matthew Porteus

Matthew Porteus, M.D., Ph.D. is an academic founder of Graphite Bio and a pioneer in the field of gene editing. Currently, he is a Professor of Pediatrics and Stem Cell Transplantation and the co-director of the Center for Definitive and Curative Medicine at Stanford University. His work in gene editing spans more than two decades, during which he was an academic founder of CRISPR Therapeutics, and an advisor to several other gene-editing companies, as well as the National Heart, Lung, and Blood Institute on Sickle Cell Disease. As a trained Pediatric Hematologist, Dr. Porteus now cares for children who are on the Pediatric Stem Cell Transplant service.